Immedica Pharma AB

It is used in the treatment of ocular hypertension and chronic open-angle glaucoma to reduce intraocular pressure.

Dosage form: drops, ophthalmic solution

ATC: S01ED02

The medicine is used to treat increased intraocular pressure in patients with chronic open-angle glaucoma or ocular hypertension.

Dosage form: drops, ophthalmic solution

ATC: S01ED02

It is intended for the treatment of symptoms of non-infectious inflammatory eye diseases that respond to corticosteroids, such as inflammation of the conjunctiva, eyelids, cornea, and the anterior segment of the eyeball.

Dosage form: drops, ophthalmic suspension

ATC: S01BA07

The medicine is intended for the treatment of symptoms of non-infectious inflammatory eye diseases that respond to corticosteroids. This includes, among others, inflammation of the conjunctiva, eyelids, cornea, and the anterior segment of the eyeball.

Dosage form: drops, ophthalmic suspension

ATC: S01BA07

It is intended for the treatment of symptoms of non-infectious inflammatory eye diseases that respond to corticosteroids, such as inflammation of the conjunctiva, eyelids, cornea, and the anterior segment of the eyeball.

Dosage form: drops, ophthalmic suspension

ATC: S01BA07

It is used in the treatment of non-infectious inflammation of the eyes. It works by preventing or reducing inflammation.

Dosage form: drops, ophthalmic suspension

ATC: S01BA07

The medicine is used to treat non-infectious inflammation of the eyes. It belongs to the group of corticosteroids, which prevent or reduce inflammation.

Dosage form: drops, ophthalmic suspension

ATC: S01BA07